Motor Neuron Disease

A Georgia-based biotechnology company has secured a U.S. patent for an exosome-based therapy to treat neuroinflammation that occurs in a range of neurodegenerative disease, according to the manufacturer.

Patients with ALS who have an expansion in the C9orf72 gene displayed a different neuropsychological profile, with greater impairment in executive function and verbal memory, than patients with ALS who did not have the expansion.